The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and spawning a ...

Americans are getting slimmer; Gallup says the obesity rate has decreased along with increased use of weight loss drugs such ...

Pedersen, Louise Rasmussen and Maggie Fick COPENHAGEN (Reuters) -Denmark's Novo Nordisk launched a rival bid for U.S. obesity ...

As more Americans turn to weight loss drugs, the U.S. adult obesity rate​ is declining, according to new survey data from ...

Metsera, Inc. is at the center of a bidding war between Novo Nordisk and Pfizer, driving its stock up 20%. Learn more about ...

Somehow, it’s becoming even harder to get a GLP-1.

( NewsNation) — The rate of adult obesity in the United States continued its gradual decline in 2025, as the use of GLP-1 ...

Novo Nordisk's late bid to hijack Pfizer's takeover of U.S. obesity biotech Metsera marks an aggressive shift from the Danish ...

The Gallup National Health and Well-Being Index shows that GLP-1 weight loss drugs are having an effect: The U.S. obesity ...

Obesity is a global epidemic affecting millions of people every day and is associated with comorbidities ranging from heart ...

After hitting a record high, the U.S. rate of obesity is falling, as the number of people taking GLP-1 medications rises ...

Founded in 2022 by Population Health Partners and ARCH Venture Partners, the biotech venture giant led by Bob Nelsen, Metsera ...